Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: A study protocol
서울특별시 동대문구 경희대로23
경희대학교 서울바이오 산학협력센터 604호
대표전화 02-961-0329
대표메일 info@jaeinrnp.com
Copyright 2021.Jaein R&P Corp, all right reserved
서울특별시 동대문구 경희대로23 경희대학교 서울바이오 산학협력센터 604호
대표전화 02-961-0329 대표메일 info@jaeinrnp.com
Copyright 2021. Jaein R&P Corp all right reserved
Medicine® / September 18, 2020
Phase I study to evaluate the maximum tolerated
dose of the combination of SH003 and
docetaxel in patients with solid cancer: A study protocol
Link;
https://journals.lww.com/md-journal/Fulltext/2020/09180/Phase_I_study_to_evaluate_the_maximum_tolerated.60.aspx